Background: Nonsteroidal anti-inflammatory drugs (NSAIDs) are the most frequent agents involved in hypersensitivity drug reactions, with NSAID-induced urticaria and/or angioedema (NIUA) being the most common entity. Mast cells are key players in NIUA and are activated by thymic stromal lymphopoietin (TSLP). This cytokine functions through recognition by its receptor, composed of IL7Rα (interleukin-7 receptor alpha) and TSLPR (TSLP receptor). These genes have been previously associated with other inflammatory diseases. Methods: We assessed the genetic association between single nucleotide polymorphisms (SNPs) in TSLP, IL7R and TSLPR and NIUA in Spanish individuals, using genotyped and imputed data. A total of 369 unrelated NIUA patients and 580 NSAID-tolerant control subjects were included, and 6 SNPs in TSLP, 6 in IL7R and 3 in TSLPR were genotyped. Further variants were imputed using Mach and the 1,000 Genomes Project (Phase 3) data. Association testing and statistical analyses were performed with Mach2dat and R. Results: A total of 139 SNPs were tested for association following quality control. Two SNPs in TSLP (rs1816678 and rs764917) showed a nominal association (p = 0.033 and 0.024, respectively) with NIUA, although these results were not statistically significant after correcting for multiple comparisons. Conclusions: Although TSLP, IL7R and TSLPR are important genes involved in the development of the inflammatory response, we found no significant genetic association with NIUA in our population for common SNPs in these genes.

1.
Dona I, Blanca-Lopez N, Cornejo-Garcia J: NSAIDs are the most frequent medicaments involved in hypersensitivity drug reactions. Eur Ann Allergy Clin Immunol 2014;46:63.
2.
Cornejo-García JA, Jagemann LR, Blanca-López N, Doña I, Flores C, Guéant-Rodríguez RM, et al: Genetic variants of the arachidonic acid pathway in non-steroidal anti-inflammatory drug-induced acute urticaria. Clin Exp Allergy 2012;42:1772-1781.
3.
Park SM, Park JS, Park HS, Park CS: Unraveling the genetic basis of aspirin hypersensitivity in asthma beyond arachidonate pathways. Allergy Asthma Immunol Res 2013;5:258-276.
4.
Losol P, Yoo HS, Park HS: Molecular genetic mechanisms of chronic urticaria. Allergy Asthma Immunol Res 2014;6:13-21.
5.
Liu YJ: Thymic stromal lymphopoietin: master switch for allergic inflammation. J Exp Med 2006;203:269-273.
6.
Ziegler SF, Liu YJ: Thymic stromal lymphopoietin in normal and pathogenic T cell development and function. Nat Immunol 2006;7:709-714.
7.
Soumelis V, Reche PA, Kanzler H, Yuan W, Edward G, Homey B, Gilliet M, Ho S, Antonenko S, Lauerma A, Smith K, Gorman D, Zurawski S, Abrams J, Menon S, McClanahan T, de Waal-Malefyt R, Bazan F, Kastelein RA, Liu YJ: Human epithelial cells trigger dendritic cell mediated allergic inflammation by producing TSLP. Nat Immunol 2002;3:673-680.
8.
Kay AB, Clark P, Maurer M, Ying S: Elevations in T-helper-2-initiating cytokines (interleukin-33, interleukin-25 and thymic stromal lymphopoietin) in lesional skin from chronic spontaneous (‘idiopathic') urticaria. Br J Dermatol 2015;172:1294-1302.
9.
Kurosawa M, Yukawa T, Hozawa S, Sutoh E: Single nucleotide polymorphisms in thymic stromal lymphopoietin gene are not associated with aspirin-exacerbated respiratory disease susceptibility - a pilot study in a Japanese population. J Allergy Ther 2015;6:214.
10.
Gao PS, Rafaels NM, Mu D, Hand T, Murray T, Boguniewicz M, Hata T, Schneider L, Hanifin JM, Gallo RL, Gao L, Beaty TH, Beck LA, Leung DY, Barnes KC: Genetic variants in thymic stromal lymphopoietin are associated with atopic dermatitis and eczema herpeticum. J Allergy Clin Immunol 2010;125:1403-1407.
11.
Miyake Y, Hitsumoto S, Tanaka K, Arakawa M: Association between TSLP polymorphisms and eczema in Japanese women: the Kyushu Okinawa Maternal and Child Health study. Inflammation 2015;38:1663-1668.
12.
Hirota T, Takahashi A, Kubo M, Tsunoda T, Tomita K, Doi S, Fujita K, Miyatake A, Enomoto T, Miyagawa T, Adachi M, Tanaka H, Niimi A, Matsumoto H, Ito I, Masuko H, Sakamoto T, Hizawa N, Taniguchi M, Lima JJ, Irvin CG, Peters SP, Himes BE, Litonjua AA, Tantisira KG, Weiss ST, Kamatani N, Nakamura Y, Tamari M: Genome-wide association study identifies three new susceptibility loci for adult asthma in the Japanese population. Nat Genet 2011;43:893-896.
13.
Torgerson DG, Ampleford EJ, Chiu GY, Gauderman WJ, Gignoux CR, Graves PE, et al: Meta-analysis of genome-wide association studies of asthma in ethnically diverse North American populations. Nat Genet 2011;43:887-892.
14.
Nilsson D, Henmyr V, Hallden C, Sall T, Kull I, Wickman M, Melen E, Cardell LO: Replication of genome-wide associations with allergic sensitization and allergic rhinitis. Allergy 2014;69:1506-1514.
15.
Rothenberg ME, Spergel JM, Sherrill JD, Annaiah K, Martin LJ, Cianferoni A, Gober L, Kim C, Glessner J, Frackelton E, Thomas K, Blanchard C, Liacouras C, Verma R, Aceves S, Collins MH, Brown-Whitehorn T, Putnam PE, Franciosi JP, Chiavacci RM, Grant SF, Abonia JP, Sleiman PM, Hakonarson H: Common variants at 5q22 associate with pediatric eosinophilic esophagitis. Nat Genet 2010;42:289-291.
16.
Ortega N, Dona I, Moreno E, Audicana MT, Barasona MJ, Berges-Gimeno MP, Blanca-Lopez N, Lobera T, Padial A, Rosado A, Torres MJ: Practical guidelines for diagnosing hypersensitivity reactions to nonsteroidal anti-inflammatory drugs. J Investig Allergol Clin Immunol 2014;24:308-323.
17.
Bellia A, Garcovich C, D'Adamo M, Lombardo M, Tesauro M, Donadel G, Gentileschi P, Lauro D, Federici M, Lauro R, Sbraccia P: Serum 25-hydroxyvitamin D levels are inversely associated with systemic inflammation in severe obese subjects. Intern Emerg Med 2013;8:33-40.
18.
Kowalski ML, Makowska JS: Seven steps to the diagnosis of NSAIDs hypersensitivity: how to apply a new classification in real practice? Allergy Asthma Immunol Res 2015;7:312-320.
19.
Frazer KA, Ballinger DG, Cox DR, Hinds DA, Stuve LL, Gibbs RA, et al: A second generation human haplotype map of over 3.1 million SNPs. Nature 2007;449:851-861.
20.
Sherrill JD, Gao PS, Stucke EM, Blanchard C, Collins MH, Putnam PE, Franciosi JP, Kushner JP, Abonia JP, Assa'ad AH, Kovacic MB, Biagini Myers JM, Bochner BS, He H, Hershey GK, Martin LJ, Rothenberg ME: Variants of thymic stromal lymphopoietin and its receptor associate with eosinophilic esophagitis. J Allergy Clin Immunol 2010;126:160-165.
21.
Purcell S, Neale B, Todd-Brown K, Thomas L, Ferreira MA, Bender D, Maller J, Sklar P, de Bakker PI, Daly MJ, Sham PC: PLINK: a tool set for whole-genome association and population-based linkage analyses. Am J Hum Genet 2007;81:559-575.
22.
Abecasis GR, Altshuler D, Auton A, Brooks LD, Durbin RM, Gibbs RA, Hurles ME, McVean GA: A map of human genome variation from population-scale sequencing. Nature 2010;467:1061-1073.
23.
Danecek P, Auton A, Abecasis G, Albers CA, Banks E, DePristo MA, Handsaker RE, Lunter G, Marth GT, Sherry ST, McVean G, Durbin R: The variant call format and VCFtools. Bioinformatics 2011;27:2156-2158.
24.
Li Y, Willer CJ, Ding J, Scheet P, Abecasis GR: MaCH: using sequence and genotype data to estimate haplotypes and unobserved genotypes. Genet Epidemiol 2010;34:816-834.
25.
Marchini J, Howie B: Genotype imputation for genome-wide association studies. Nat Rev Genet 2010;11:499-511.
26.
Pruim RJ, Welch RP, Sanna S, Teslovich TM, Chines PS, Gliedt TP, Boehnke M, Abecasis GR, Willer CJ: LocusZoom: regional visualization of genome-wide association scan results. Bioinformatics 2010;26:2336-2337.
27.
Storey JD, Tibshirani R: Statistical significance for genome-wide studies. Proc Natl Acad Sci USA 2003;100:9440-9445.
28.
Varga EM, Jacobson MR, Masuyama K, Rak S, Till SJ, Darby Y, Hamid Q, Lund V, Scadding GK, Durham SR: Inflammatory cell populations and cytokine mRNA expression in the nasal mucosa in aspirin-sensitive rhinitis. Eur Respir J 1999;14:610-615.
29.
Steinke JW, Payne SC, Borish L: Interleukin-4 in the generation of the AERD phenotype: implications for molecular mechanisms driving therapeutic benefit of aspirin desensitization. J Allergy (Cairo) 2012;2012:182090.
30.
Liang Y, Chang C, Lu Q: The genetics and epigenetics of atopic dermatitis-filaggrin and other polymorphisms. Clin Rev Allergy Immunol 2015, Epub ahead of print.
31.
Potaczek DP, Sanak M, Mastalerz L, Setkowicz M, Kaczor M, Nizankowska E, Szczeklik A: The alpha-chain of high-affinity receptor for IgE (FcεRIα) gene polymorphisms and serum IgE levels. Allergy 2006;61:1230-1233.
32.
Potaczek DP, Nishiyama C, Sanak M, Szczeklik A, Okumura K: Genetic variability of the high-affinity IgE receptor alpha-subunit (FcεRIα). Immunol Res 2009;45:75-84.
33.
Bae JS, Kim SH, Ye YM, Yoon HJ, Suh CH, Nahm DH, Park HS: Significant association of FcεRIα promoter polymorphisms with aspirin-intolerant chronic urticaria. J Allergy Clin Immunol 2007;119:449-456.
34.
Palikhe NS, Kim SH, Cho BY, Ye YM, Hur GY, Park HS: Association of three sets of high-affinity IgE receptor (FcεR1) polymorphisms with aspirin-intolerant asthma. Respir Med 2008;102:1132-1139.
35.
He JQ, Hallstrand TS, Knight D, Chan-Yeung M, Sandford A, Tripp B, Zamar D, Bosse Y, Kozyrskyj AL, James A, Laprise C, Daley D: A thymic stromal lymphopoietin gene variant is associated with asthma and airway hyperresponsiveness. J Allergy Clin Immunol 2009;124:222-229.
36.
Zhang Y, Wang X, Zhang W, Han D, Zhang L, Bachert C: Polymorphisms in thymic stromal lymphopoietin gene demonstrate a gender and nasal polyposis-dependent association with chronic rhinosinusitis. Hum Immunol 2013;74:241-248.
37.
Bunyavanich S, Melen E, Wilk JB, Granada M, Soto-Quiros ME, Avila L, Lasky-Su J, Hunninghake GM, Wickman M, Pershagen G, O'Connor GT, Weiss ST, Celedon JC: Thymic stromal lymphopoietin (TSLP) is associated with allergic rhinitis in children with asthma. Clin Mol Allergy 2011;9:1.
38.
Ward LD, Kellis M: HaploReg: a resource for exploring chromatin states, conservation, and regulatory motif alterations within sets of genetically linked variants. Nucleic Acids Res 2012;40:D930-D934.
39.
Kiss M, Czimmerer Z, Nagy L: The role of lipid-activated nuclear receptors in shaping macrophage and dendritic cell function: from physiology to pathology. J Allergy Clin Immunol 2013;132:264-286.
40.
Mao XR, Moerman-Herzog AM, Chen Y, Barger SW: Unique aspects of transcriptional regulation in neurons - nuances in NFκB and Sp1-related factors. J Neuroinflammation 2009;6:16.
41.
Ravasi T, Suzuki H, Cannistraci CV, Katayama S, Bajic VB, Tan K, et al: An atlas of combinatorial transcriptional regulation in mouse and man. Cell 2010;140:744-752.
42.
Kurosu T, Zhang F, Peterlin BM: Transcriptional activity and substrate recognition of cyclin T2 from P-TEFb. Gene 2004;343:173-179.
43.
Mouthon MA, Bernard O, Mitjavila MT, Romeo PH, Vainchenker W, Mathieu-Mahul D: Expression of tal-1 and GATA-binding proteins during human hematopoiesis. Blood 1993;81:647-655.
44.
Zon LI, Yamaguchi Y, Yee K, Albee EA, Kimura A, Bennett JC, Orkin SH, Ackerman SJ: Expression of mRNA for the GATA-binding proteins in human eosinophils and basophils: potential role in gene transcription. Blood 1993;81:3234-3241.
45.
Tamauchi H, Amoh Y, Itoh M, Terashima M, Masuzawa M, Habu S, Katsuoka K, Iwabuchi K: GATA-3 regulates contact hyperresponsiveness in a murine model of allergic dermatitis. Immunobiology 2012;217:446-454.
46.
Bae CJ, Lee JW, Shim SB, Jee SW, Lee SH, Woo JM, Lee CK, Hwang DY: GATA binding protein 3 overexpression and suppression significantly contribute to the regulation of allergic skin inflammation. Int J Mol Med 2011;28:171-179.
47.
Cornejo-Garcia JA, Fernandez TD, Torres MJ, Carballo M, Hernan I, Antunez C, Blanca M, Mayorga C: Differential cytokine and transcription factor expression in patients with allergic reactions to drugs. Allergy 2007;62:1429-1438.
48.
Maneechotesuwan K, Yao X, Ito K, Jazrawi E, Usmani OS, Adcock IM, Barnes PJ: Suppression of GATA-3 nuclear import and phosphorylation: a novel mechanism of corticosteroid action in allergic disease. PLoS Med 2009;6:e1000076.
49.
Adcock IM, Tsaprouni L, Bhavsar P, Ito K: Epigenetic regulation of airway inflammation. Curr Opin Immunol 2007;19:694-700.
50.
Kobayashi Y, Bossley C, Gupta A, Akashi K, Tsartsali L, Mercado N, Barnes PJ, Bush A, Ito K: Passive smoking impairs histone deacetylase-2 in children with severe asthma. Chest 2014;145:305-312.
51.
Bhavsar P, Ahmad T, Adcock IM: The role of histone deacetylases in asthma and allergic diseases. J Allergy Clin Immunol 2008;121:580-584.
52.
Sohal SS, Reid D, Soltani A, Weston S, Muller HK, Wood-Baker R, Walters EH: Changes in airway histone deacetylase2 in smokers and COPD with inhaled corticosteroids: a randomized controlled trial. PLoS One 2013;8:e64833.
53.
Cho JS, Moon YM, Park IH, Um JY, Kang JH, Kim TH, Lee SH, Kang HJ, Lee HM: Effects of histone deacetylase inhibitor on extracellular matrix production in human nasal polyp organ cultures. Am J Rhinol Allergy 2013;27:18-23.
54.
Park LS, Martin U, Garka K, Gliniak B, Di Santo JP, Muller W, Largaespada DA, Copeland NG, Jenkins NA, Farr AG, Ziegler SF, Morrissey PJ, Paxton R, Sims JE: Cloning of the murine thymic stromal lymphopoietin (TSLP) receptor: formation of a functional heteromeric complex requires interleukin 7 receptor. J Exp Med 2000;192:659-670.
55.
Wang XS, Wen PF, Zhang M, Hu LF, Ni J, Qiu LJ, Liang Y, Zhao W, Huang Q, Tao SS, Xu WD, Feng CC, Cen H, Leng RX, Pan HF, Ye DQ: Interleukin-7 receptor single nucleotide polymorphism rs6897932 (C/T) and the susceptibility to systemic lupus erythematosus. Inflammation 2014;37:615-620.
56.
Abramson SB: Clinical guidelines: expert recommendations for NSAID use: a user-friendly model? Nat Rev Rheumatol 2011;7:133-134.
57.
Dona I, Barrionuevo E, Blanca-Lopez N, Torres MJ, Fernandez TD, Mayorga C, Canto G, Blanca M: Trends in hypersensitivity drug reactions: more drugs, more response patterns, more heterogeneity. J Investig Allergol Clin Immunol 2014;24:143-153.
58.
Ye YM, Kim MK, Kang HR, Kim TB, Sohn SW, Koh YI, Park HK, Jang GC, Kim CW, Jee YK, Hur GY, Kim JH, Kim SH, Choi GS, Lee SK, Park HS: Predictors of the severity and serious outcomes of anaphylaxis in Korean adults: a multicenter retrospective case study. Allergy Asthma Immunol Res 2015;7:22-29.
59.
Kim SH, Sanak M, Park HS: Genetics of hypersensitivity to aspirin and nonsteroidal anti-inflammatory drugs. Immunol Allergy Clin North Am 2013;33:177-194.
60.
Agundez JA, Ayuso P, Cornejo-Garcia JA, Blanca M, Torres MJ, Dona I, Salas M, Blanca-Lopez N, Canto G, Rondon C, Campo P, Laguna JJ, Fernandez J, Martinez C, Garcia-Martin E: The diamine oxidase gene is associated with hypersensitivity response to non-steroidal anti-inflammatory drugs. PLoS One 2012;7:e47571.
61.
Ayuso P, Blanca M, Cornejo-Garcia JA, Torres MJ, Dona I, Salas M, Blanca-Lopez N, Canto G, Rondon C, Campo P, Laguna JJ, Fernandez J, Martinez C, Agundez JA, Garcia-Martin E: Variability in histamine receptor genes HRH1, HRH2 and HRH4 in patients with hypersensitivity to NSAIDs. Pharmacogenomics 2013;14:1871-1878.
62.
Cornejo-Garcia JA, Flores C, Plaza-Seron MC, Acosta-Herrera M, Blanca-Lopez N, Dona I, Torres MJ, Mayorga C, Gueant- Rodriguez RM, Ayuso P, Fernandez J, Laguna JJ, Agundez JA, Garcia-Martin E, Gueant JL, Canto G, Blanca M: Variants of CEP68 gene are associated with acute urticaria/angioedema induced by multiple non-steroidal anti-inflammatory drugs. PLoS One 2014;9:e90966.
63.
Cornejo-Garcia JA, Liou LB, Blanca-Lopez N, Dona I, Chen CH, Chou YC, Chuang HP, Wu JY, Chen YT, Plaza-Seron Mdel C, Mayorga C, Gueant-Rodriguez RM, Lin SC, Torres MJ, Campo P, Rondon C, Laguna JJ, Fernandez J, Gueant JL, Canto G, Blanca M, Lee MT: Genome-wide association study in NSAID-induced acute urticaria/angioedema in Spanish and Han Chinese populations. Pharmacogenomics 2013;14:1857-1869.
64.
Sanchez-Borges M, Caballero-Fonseca F, Capriles-Hulett A, Gonzalez-Aveledo L: Aspirin-exacerbated cutaneous disease (AECD) is a distinct subphenotype of chronic spontaneous urticaria. J Eur Acad Dermatol Venereol 2015;29:698-701.
65.
Dona I, Blanca-Lopez N, Torres MJ, Gomez F, Fernandez J, Zambonino MA, Monteseirin FJ, Canto G, Blanca M, Cornejo-Garcia JA: NSAID-induced urticaria/angioedema does not evolve into chronic urticaria: a 12-year follow-up study. Allergy 2014;69:438-444.
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.